This was in contrast to the increased tumour burden in normal mice with long telomeres after Tert gene therapy (Artandi et al., 2002), which was exacerbated in mice with a tumour suppressor gene (p53) mutation (Gonzalez‐Suarez et al., 2002). Here, TP53 is linked to neoplasm.